Development of decision trees to discriminate HDAC8 inhibitors and non-inhibitors using recursive partitioning

Histone deacetylase 8 (HDAC8) is involved in malignancy. Overexpression of HDAC8 is correlated with various cancers. Design of selective HDAC8 inhibitors is always a challenging task to the chemistry audiences. In this communication, a diverse set comprising large number of compounds are subjected to recursive partitioning (RP) analysis to develop decision trees to discriminate compounds into HDAC8 inhibitors (active) and non-inhibitors (inactive). Acquiring knowledge about the essential structural and physicochemical parameters can be useful in designing potential and selective HDAC8 inhibitors. Moreover, this work validates our previous results observed in Bayesian modelling study of this dataset. This comparative learning will surely enrich drug discovery aspects related to HDAC8 inhibitors.Communicated by Ramaswamy H. Sarma.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:39

Enthalten in:

Journal of biomolecular structure & dynamics - 39(2021), 1 vom: 15. Jan., Seite 1-8

Sprache:

Englisch

Beteiligte Personen:

Amin, Sk Abdul [VerfasserIn]
Adhikari, Nilanjan [VerfasserIn]
Jha, Tarun [VerfasserIn]

Links:

Volltext

Themen:

Cancer
Decision tree
ECFP_6
FCFP_6
HDAC8 inhibitor
Histone Deacetylase Inhibitors
Journal Article
Molecular fingerprint
Recursive partitioning model

Anmerkungen:

Date Completed 18.06.2021

Date Revised 18.06.2021

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1080/07391102.2019.1661876

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM301385467